share_log

Bioasis Technologies Inc. (OTCMKTS:BIOAF) Short Interest Up 32.4% in August

Bioasis Technologies Inc. (OTCMKTS:BIOAF) Short Interest Up 32.4% in August

空頭股數8月份上漲32.4%
Financial News Live ·  2022/09/18 23:51

Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) was the target of a large growth in short interest in the month of August. As of August 31st, there was short interest totalling 56,400 shares, a growth of 32.4% from the August 15th total of 42,600 shares. Based on an average trading volume of 29,900 shares, the short-interest ratio is presently 1.9 days.

生物綠洲科技公司(BiOASIS Technologies Inc.)是8月份空頭股數大幅增長的目標。截至8月31日,空頭股數共有56,400股,較8月15日的42,600股增長32.4%。以平均成交量29,900股計算,目前短息比率為1.9天。

Bioasis Technologies Stock Performance

BiOASIS科技股表現

BIOAF remained flat at $0.13 during midday trading on Friday. The firm's fifty day moving average is $0.12 and its 200 day moving average is $0.16. Bioasis Technologies has a 52-week low of $0.10 and a 52-week high of $0.28.

週五午盤,BIOAF持平於0.13美元。該公司的50日移動均線切入位為0.12美元,200日移動均線切入位為0.16美元。BiOasis Technologies的52周低點為0.10美元,52周高位為0.28美元。

Get
到達
Bioasis Technologies
BiOASIS技術
alerts:
警報:

About Bioasis Technologies

關於BiOASIS技術公司

(Get Rating)

(獲取評級)

Bioasis Technologies Inc, a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the transport of therapeutic agents across the blood-brain barrier (BBB); and the treatment of central nervous system disorders (CNS), including brain cancers, and metabolic and neurodegenerative diseases.
BiOASIS技術公司是一家處於發展階段的生物製藥公司,致力於神經疾病和障礙的診斷和治療產品的研究和開發。它正在開發xB3,這是一種通過血腦屏障(BBB)運輸治療劑的平臺技術;以及治療中樞神經系統疾病(CNS),包括腦癌,以及代謝和神經退行性疾病。

Featured Stories

專題報道

  • Get a free copy of the StockNews.com research report on Bioasis Technologies (BIOAF)
  • 3 Banks Worth Considering For Q4
  • Stock Market: 3 Islands Of Strength In A Sea Of Red
  • MarketBeat: Week in Review 9/12 – 9/16
  • No One Told These 3 Stocks It's a Down Week
  • Is There a Cure for What is Ailing Teladoc Stock?
  • 免費獲取StockNews.com關於BiOASIS技術的研究報告(BIOAF)
  • 第四季度值得考慮的3家銀行
  • 股市:紅海中的三座強國
  • MarketBeat:回顧一週9/12-9/16
  • 沒有人告訴這三隻股票這是下跌的一週
  • 有什麼辦法可以治癒Teladoc股票的問題嗎?

Receive News & Ratings for Bioasis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioasis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

接受《BiOASIS技術日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊,接收最新新聞和分析師對BiOasis Technologies及相關公司的評級的每日摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論